Evidence map›Paper›PMID 20951119›Full record

ArticleBiochemical pharmacology2011

Targeting maladaptive glutathione responses in lung disease.

Neal S Gould, Brian J Day

Abstract read
In one paragraph

Article in Biochemical pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. The Beneficial Effects of Antioxidants in Health And Diseases.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2020
    Review
  14. Article
  15. Article
  16. Review
  17. Glutathione Depletion Accelerates Cigarette Smoke-Induced Inflammation and Airspace Enlargement.Toxicological sciences : an official journal of the Society of Toxicology · 2015
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Neal S GouldDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Brian J Day

Funding

Thiols in sulfur mustard toxicityU54ES015678 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI WHITE, CARL W · 2006 to 2015
$20.5M
Targeting Oxidative Stress in Chronic Beryllium DiseaseR01ES017582 · NIEHS · NATIONAL JEWISH HEALTH · PI DAY, BRIAN J, MAIER, LISA A · 2009 to 2013
$1.7M
Adaptive glutathione responses to cigarette smoke in COPDR01HL084469 · NHLBI · NATIONAL JEWISH HEALTH · PI DAY, BRIAN J · 2008 to 2011
$1.6M
Glutathione transport, oxidative stress and lung injuryR01HL075523 · NHLBI · NATIONAL JEWISH HEALTH · PI DAY, BRIAN J · 2004 to 2007
$1.3M
NHLBI NIH HHS R01 HL075523NHLBI NIH HHS R01 HL084469NIEHS NIH HHS R01 ES017582NIEHS NIH HHS U54 ES015678
6 · The paper itself

Abstract

The lung is unique being exposed directly to the atmospheric environment containing xenobiotics, pathogens, and other agents which are continuously inhaled on a daily basis. Additionally, the lung is exposed to higher ambient oxygen levels which can promote the formation of a complex number of reactive oxygen and nitrogen species. Due to this constant barrage of potential damaging agents, the lung has developed a high degree of plasticity in dealing with ever changing conditions. In the present commentary, we will focus on glutathione (GSH) as a key antioxidant in the lung airways and discuss mechanisms by which the lung uses GSH to adapt to its rapidly changing environment. We will then examine the evidence on how defective and inadequate adaptive responses can lead to lung injury, inflammation and disease. Lastly, we will examine some of the recent attempts to alter lung GSH levels with therapies in a number of human lung diseases and discuss some of the limitations of such approaches.

Indexed as

AcetylcysteineAnimalsAntioxidantsBronchoalveolar Lavage FluidGlutathioneHumansLungLung DiseasesOxidation-ReductionAcetylcysteineAntioxidantsGlutathione

Identifiers

PMID20951119
PMCPMC3039114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.